A detailed history of Rothschild Investment Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Rothschild Investment Corp holds 8,766 shares of LLY stock, worth $6.87 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
8,766
Previous 8,595 1.99%
Holding current value
$6.87 Million
Previous $4.03 Million 16.82%
% of portfolio
0.4%
Previous 0.34%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

BUY
$434.7 - $599.3 $74,333 - $102,480
171 Added 1.99%
8,766 $4.71 Million
Q2 2023

Jul 18, 2023

BUY
$350.74 - $468.98 $99,960 - $133,659
285 Added 3.43%
8,595 $4.03 Million
Q1 2023

Apr 24, 2023

SELL
$310.63 - $364.82 $71,134 - $83,543
-229 Reduced 2.68%
8,310 $2.85 Million
Q4 2022

Jan 19, 2023

SELL
$321.55 - $374.67 $93,892 - $109,403
-292 Reduced 3.31%
8,539 $3.12 Million
Q3 2022

Oct 21, 2022

SELL
$296.48 - $337.87 $1.02 Million - $1.16 Million
-3,438 Reduced 28.02%
8,831 $2.86 Million
Q2 2022

Jul 12, 2022

SELL
$278.73 - $327.27 $158,597 - $186,216
-569 Reduced 4.43%
12,269 $3.98 Million
Q1 2022

Apr 18, 2022

SELL
$234.69 - $291.66 $2,112 - $2,624
-9 Reduced 0.07%
12,838 $3.68 Million
Q4 2021

Jan 24, 2022

SELL
$224.85 - $279.04 $207,311 - $257,274
-922 Reduced 6.7%
12,847 $3.55 Million
Q3 2021

Oct 12, 2021

SELL
$221.6 - $272.71 $207,417 - $255,256
-936 Reduced 6.37%
13,769 $3.18 Million
Q2 2021

Jul 19, 2021

SELL
$180.55 - $233.54 $205,646 - $266,002
-1,139 Reduced 7.19%
14,705 $3.38 Million
Q1 2021

Apr 15, 2021

SELL
$164.32 - $212.72 $492 - $638
-3 Reduced 0.02%
15,844 $2.96 Million
Q4 2020

Jan 25, 2021

BUY
$130.46 - $172.63 $92,104 - $121,876
706 Added 4.66%
15,847 $2.68 Million
Q3 2020

Oct 22, 2020

BUY
$146.22 - $169.13 $165,959 - $191,962
1,135 Added 8.1%
15,141 $2.24 Million
Q2 2020

Jul 24, 2020

SELL
$136.42 - $164.18 $16,097 - $19,373
-118 Reduced 0.84%
14,006 $2.3 Million
Q1 2020

Apr 16, 2020

SELL
$119.05 - $147.35 $9,047 - $11,198
-76 Reduced 0.54%
14,124 $1.96 Million
Q4 2019

Jan 22, 2020

SELL
$106.92 - $132.43 $83,932 - $103,957
-785 Reduced 5.24%
14,200 $1.87 Million
Q3 2019

Oct 11, 2019

SELL
$106.79 - $116.16 $961 - $1,045
-9 Reduced 0.06%
14,985 $1.68 Million
Q2 2019

Jul 11, 2019

SELL
$110.79 - $129.32 $90,847 - $106,042
-820 Reduced 5.19%
14,994 $1.66 Million
Q1 2019

Apr 18, 2019

SELL
$111.31 - $131.02 $44,412 - $52,276
-399 Reduced 2.46%
15,814 $2.05 Million
Q4 2018

Jan 28, 2019

BUY
$105.9 - $118.64 $847 - $949
8 Added 0.05%
16,213 $1.88 Million
Q3 2018

Oct 17, 2018

SELL
$85.86 - $107.31 $1,631 - $2,038
-19 Reduced 0.12%
16,205 $1.74 Million
Q2 2018

Jul 24, 2018

SELL
$75.7 - $86.88 $17,335 - $19,895
-229 Reduced 1.39%
16,224 $1.38 Million
Q1 2018

Apr 27, 2018

SELL
$74.21 - $87.6 $719,317 - $849,106
-9,693 Reduced 37.07%
16,453 $1.27 Million
Q4 2017

Jan 23, 2018

SELL
$81.94 - $87.89 $28,597 - $30,673
-349 Reduced 1.32%
26,146 $2.21 Million
Q3 2017

Oct 25, 2017

BUY
$77.07 - $85.54 $2.04 Million - $2.27 Million
26,495
26,495 $2.27 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rothschild Investment Corp Portfolio

Follow Rothschild Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.